ASN Kidney Week 2024 – Advances in Research Conference – Genome Engineering and RNA-Based Therapeutics From Bench to Potentially Curative Medicines

ASN Kidney Week 2024 – Advances in Research Conference – Genome Engineering and RNA-Based Therapeutics From Bench to Potentially Curative Medicines

Kidney Week 2024: Early Programs

Each Early Program addresses a specific topic in nephrology and requires separate registration from the Annual Meeting.

• • Advances in Research Conference – Genome Engineering and RNA-Based Therapeutics: From Bench to Potentially Curative Medicines

    Advances in Research Conference – Genome Engineering and RNA-Based Therapeutics: From Bench to Potentially Curative Medicines

    October 23, 2024 | 07:00 AM PDT – 05:10 PM PDT

    Location: Room 6A, Convention Center

    Session Description

    
    This program showcases cutting-edge advances in gene therapy, genome and epigenome editing, and RNA-based therapeutics. Lectures highlight recent technological advances, the current toolbox available to clinicians, and major clinical breakthroughs, with an eye toward potential application to the treatment of kidney diseases.
    

    Session Objectives

    
    Upon completion of this program, the participant will be able to: 1) describe state-of-the-art genome editing and RNA-based therapeutics technology; 2) discuss the potential clinical application of genome editing for kidney-related diseases; and 3) discuss the potential clinical application of RNA-based drugs for common kidney diseases.
    

    Learning Pathway(s)

    • Genetic Diseases and Development

    Moderators

    • Opeyemi A. Olabisi, MD, PhD
    • Vishal Patel, MD

    Presentations

    • Check In and Continental Breakfast 07:00 AM PDT – 08:00 AM PDT
      
      
    • Welcome and Opening Remarks 08:00 AM PDT – 08:10 AM PDT
      
      
      • Vishal Patel, MD
    • Base Editing and Prime Editing: Technology and Toolbox for Correcting DNA Variants 08:10 AM PDT – 08:40 AM PDT
      
      
      • Andrew Anzalone, MD, PhD
    • Targeting the Kidneys for Gene Therapy 08:40 AM PDT – 09:10 AM PDT
      
      
      • Matthew H. Wilson, MD, PhD
    • Back to the Microbes: Searching for New and Diverse Gene-Editing Tools 09:10 AM PDT – 09:40 AM PDT
      
      
      • Brian C. Thomas, PhD
    • Break 09:40 AM PDT – 10:15 AM PDT
      
      
    • Delivery Approaches to Carry Genetic Cargo to Kidneys 10:15 AM PDT – 10:45 AM PDT
      
      
      • Eun ji Chung, PhD
    • RNA Editing as a Novel Therapeutic Modality 10:45 AM PDT – 11:15 AM PDT
      
      
      • Chikdu S. Shivalila, PhD
    • AAV Vector-Mediated Gene Therapy for Alport Syndrome 11:15 AM PDT – 11:45 AM PDT
      
      
      • Hiroyuki Nakai, MD, PhD
    • Lunch (on your own) 11:45 AM PDT – 01:00 PM PDT
      
      
    • CRISPR for the Treatment of Sickle Cell Disease 01:00 PM PDT – 01:30 PM PDT
      
      
      • Alexis A. Thompson, MD, MPH
    • Gene Therapy for Podocytopathies 01:30 PM PDT – 02:00 PM PDT
      
      
      • Moin A. Saleem, MD, MBBS, MBChB, PhD
    • RNA Interference in the Treatment of Kidney Stone Disease 02:00 PM PDT – 02:30 PM PDT
      
      
      • John C. Lieske, MD, FASN
    • Break 02:30 PM PDT – 03:00 PM PDT
      
      
    • RNAi Drugs to Treat Hypertension 03:00 PM PDT – 03:30 PM PDT
      
      
      • Rhian Touyz, MD, MBChB, PhD
    • miRNA Therapeutics for Polycystic Kidney Disease 03:30 PM PDT – 04:00 PM PDT
      
      
      • Edmund Chun Yu Lee, PhD
    • Antisense Oligonucleotide Therapy for APOL1-Mediated Kidney Disease 04:00 PM PDT – 04:30 PM PDT
      
      
      • Peter J. Greasley, PhD
    • Antisense Oligonucleotide Therapy for Preeclampsia 04:30 PM PDT – 05:00 PM PDT
      
      
      • S. Ananth Karumanchi, MD
    • Closing Remarks 05:00 PM PDT – 05:10 PM PDT
      
      
      • Opeyemi A. Olabisi, MD, PhD